Who owns Applied Therapeutics Inc?
- Ticker: APLT
- CUSIP Number: 03828a101
Tip: Access positions for across all investors
Analyze quarterly positions in Applied Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Applied Therapeutics stock
Who bought or sold Applied Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Franklin Resources | 11M | $72M | 51% | Mar 2024 |
|
| VR Adviser | 9.1M | $62M | 45% | Mar 2024 |
|
| Perceptive Advisors | 8.5M | $58M | 86% | Mar 2024 |
|
| Henderson Group | 6.4M | $44M | 199% | Mar 2024 |
|
| Propel Bio Management | 6.1M | $42M | 14% | Mar 2024 |
|
| Knoll Capital Management | 5.6M | $38M | 2% | Mar 2024 |
|
| Alyeska Investment Group | 5.4M | $37M | -46% | Mar 2024 |
|
| Morgan Stanley | 3.2M | $22M | 6118% | Mar 2024 |
|
| Vanguard Group | 3.0M | $21M | -7% | Mar 2024 |
|
| Simplify Asset Management | 2.8M | $19M | 17% | Mar 2024 |
|
| Adage Capital Partners GP | 2.6M | $18M | 100% | Mar 2024 |
|
| Tang Capital Management | 2.2M | $15M | 100% | Mar 2024 |
|
| Frazier Life Sciences Management | 2.0M | $13M | 100% | Mar 2024 |
|
| Parkman Healthcare Partners | 1.9M | $13M | 6% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 1.8M | $13M | 274% | Mar 2024 |
|
| Opaleye Management | 1.8M | $3.7M | 62% | Mar 2024 |
|
| Soleus Capital Management | 1.6M | $11M | 240% | Mar 2024 |
|
| Rock Springs Capital Management | 1.5M | $10M | 85% | Mar 2024 |
|
| Laurion Capital Management | 1.5M | $10M | 244% | Mar 2024 |
|
| Logos Global Management | 1.4M | $9.0M | -19% | Mar 2024 |
|
| Susquehanna International | 1.3M | $8.7M | 215% | Mar 2024 |
|
| Artal Group | 1.0M | $6.9M | 100% | Mar 2024 |
|
| BlackRock | 989k | $6.7M | 158% | Mar 2024 |
|
| Millennium Management | 926k | $6.3M | 54% | Mar 2024 |
|
| Goldman Sachs Group | 715k | $4.9M | 4169% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 622k | $4.2M | 100% | Mar 2024 |
|
| Sphera Funds Management | 619k | $4.2M | 100% | Mar 2024 |
|
| Geode Capital Management | 604k | $4.1M | 36% | Mar 2024 |
|
| ADAR1 Capital Management | 487k | $3.3M | 100% | Mar 2024 |
|
| J. Goldman & Co | 484k | $3.3M | 100% | Mar 2024 |
|
| Qube Research & Technologies | 459k | $3.1M | 5981% | Mar 2024 |
|
| Walleye Trading Advisors | 308k | $2.1M | 1714% | Mar 2024 |
|
| Jane Street | 245k | $1.7M | 85% | Mar 2024 |
|
| Checkpoint Capital | 220k | $1.5M | 100% | Mar 2024 |
|
| Squarepoint Ops | 194k | $1.3M | 1292% | Mar 2024 |
|
| LMR Partners | 181k | $1.2M | 52% | Mar 2024 |
|
| Jpmorgan Chase & Co | 179k | $1.2M | 281% | Mar 2024 |
|
| Bridgeway Capital Management | 174k | $1.2M | 21% | Mar 2024 |
|
| Cubist Systematic Strategies | 163k | $1.1M | 178% | Mar 2024 |
|
| Two Sigma Investments | 155k | $1.1M | -46% | Mar 2024 |
|
| Man Group | 155k | $1.1M | -7% | Mar 2024 |
|
| UBS Group | 153k | $1.0M | 27% | Mar 2024 |
|
| Citadel Advisors | 130k | $883k | -17% | Mar 2024 |
|
| Citigroup | 119k | $808k | -46% | Mar 2024 |
|
| Northern Trust | 107k | $724k | 8% | Mar 2024 |
|
| Hrt Financial | 99k | $672k | 100% | Mar 2024 |
|
| Parallax Volatility Advisers | 96k | $654k | 100% | Mar 2024 |
|
| Eudaimonia Asset Management | 93k | $632k | -76% | Mar 2024 |
|
| Richmond Brothers | 62k | $420k | -50% | Mar 2024 |
|
| Barclays | 61k | $417k | 100% | Mar 2024 |
|
| ExodusPoint Capital Management | 61k | $413k | 100% | Mar 2024 |
|
| Marathon Trading Investment Management | 59k | $401k | 100% | Mar 2024 |
|
| Brevan Howard Capital Management | 47k | $322k | 100% | Mar 2024 |
|
| Relyea Zuckerberg Hanson | 40k | $272k | 0% | Mar 2024 |
|
| Engineers Gate Manager | 40k | $270k | 100% | Mar 2024 |
|
| Point72 Asia | 37k | $253k | 1181% | Mar 2024 |
|
| Bank of America Corporation | 36k | $242k | -20% | Mar 2024 |
|
| Denali Advisors | 34k | $229k | 100% | Mar 2024 |
|
| Caption Management | 31k | $213k | 100% | Mar 2024 |
|
| Y-Intercept | 27k | $184k | 100% | Mar 2024 |
|
| Polymer Capital Management | 26k | $176k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 25k | $167k | 0% | Mar 2024 |
|
| Jump Financial | 24k | $81k | 100% | Dec 2023 |
|
| Leucadia National Corporation | 22k | $151k | 100% | Mar 2024 |
|
| GSA Capital Partners | 21k | $146k | 100% | Mar 2024 |
|
| Wealthtrust Axiom | 21k | $143k | -51% | Mar 2024 |
|
| Belvedere Trading | 17k | $114k | 100% | Mar 2024 |
|
| Susquehanna Portfolio Strategies | 14k | $96k | 100% | Mar 2024 |
|
| Commonwealth Equity Services | 14k | $92k | 0% | Mar 2024 |
|
| Perennial Investment Advisors | 12k | $79k | 0% | Mar 2024 |
|
| Raymond James & Associates | 11k | $73k | 100% | Mar 2024 |
|
| CTC Alternative Strategies | 10k | $71k | 100% | Mar 2024 |
|
| Tower Research Capital | 10k | $70k | -71% | Mar 2024 |
|
| Brian McDonald | 2.0k | $14k | 0% | Mar 2024 |
|
| Cutler | 700.00 | $4.0k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 544.00 | $3.7k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 435.00 | $3.0k | 2% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 84.00 | $570.998400 | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.00 | $7.000000 | 0% | Mar 2024 |
|
Who sold out of Applied Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Sep 2023 | 3.4M | $8.5M |
| FMR | Sep 2023 | 2.6M | $6.6M |
| AIGH Capital Management | Dec 2023 | 1.7M | $5.6M |
| Point72 Asset Management | Dec 2023 | 475k | $1.6M |
| Worth Venture Partners | Dec 2023 | 413k | $1.4M |
| Marshall Wace | Dec 2023 | 258k | $865k |
| 683 Capital Management | Dec 2023 | 101k | $338k |
| Connective Capital Management | Dec 2023 | 79k | $266k |
| Simplex Trading | Dec 2023 | 72k | $241k |
| Springbok Capital Management | Sep 2023 | 64k | $158k |
| Two Sigma Advisers | Dec 2023 | 51k | $171k |
| Maven Securities | Dec 2023 | 50k | $168k |
| Wolverine Trading | Dec 2023 | 33k | $111k |
| Bank of New York Mellon | Dec 2023 | 27k | $90k |
| Two Sigma Securities | Dec 2023 | 19k | $63k |
| Us Bancorp | Dec 2023 | 18k | $61k |
| Balyasny Asset Management | Dec 2023 | 11k | $36k |
| Vontobel Holding | Dec 2023 | 10k | $34k |
| Essex Financial Services | Dec 2023 | 10k | $34k |
| Royal Bank of Canada | Dec 2023 | 2.1k | $7.0k |